Skip to main content
Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.00
-0.37 (-1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed

AAPG Revenue

In the year 2025, Ascentage Pharma Group International had annual revenue of 574.12M CNY, down -41.46%. Ascentage Pharma Group International had revenue of 340.42M in the half year ending December 31, 2025, with 329.37% growth.

Revenue (ttm)
574.12M CNY
Revenue Growth
-41.46%
P/S Ratio
26.28
Revenue / Employee
748,527 CNY
Employees
767
Market Cap
2.16B USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025574.12M-406.53M-41.46%
Dec 31, 2024980.65M758.67M341.77%
Dec 31, 2023221.98M12.27M5.85%
Dec 31, 2022209.71M181.80M651.38%
Dec 31, 202127.91M15.46M124.18%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sarepta Therapeutics 2.20B
Ultragenyx Pharmaceutical 673.00M
Aurinia Pharmaceuticals 283.06M
Adaptive Biotechnologies 276.98M
Zymeworks 105.97M
Mesoblast 65.38M
Ocular Therapeutix 51.95M
Capricor Therapeutics 11.13M
Revenue Rankings

AAPG News

More News